Food and Drug Regulations, C.R.C., c. 870
Section C.03.315
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.03.315 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) The sponsor shall record, handle and store all information in respect of a study in a way that allows it to be reported completely and accurately and to be interpreted and verified.
(2) The sponsor shall maintain complete and accurate records to establish that the study is conducted in accordance with these Regulations.
(3) The sponsor shall maintain all of the following records in respect of the use of the study drug in each study:
(a) records respecting all adverse reactions that occur inside or outside Canada, including the indications for use and the dosage form of the study drug at the time of the adverse reaction;
(b) written procedures for subject monitoring and for the documentation and reporting of adverse reactions;
(c) articles from scientific journals or other publications that were used in support of the safety profile of the study drug in respect of humans;
(d) records in respect of each study subject, including respecting their enrolment, a copy of their signed consent form and sufficient information to enable them to be identified and contacted in the event that the sale of the study drug may endanger their health or that of another person;
(e) records respecting the shipment, receipt, sale, return and destruction or other disposition of the study drug;
(f) for each study site, an undertaking, dated and signed by the qualified investigator before the start of the study, that they will
(i) conduct the study in accordance with good clinical practices, and
(ii) on discontinuance of the study by the sponsor, for any reason related to health or safety, immediately inform both the study subjects and the research ethics board of the discontinuance, provide them with the reasons for the discontinuance and advise them in writing of any potential risks to the health of study subjects or other persons;
(g) for each study site, a copy of the informed consent form; and
(h) for each study site, a copy of the certifying statement described in paragraph C.03.307(2)(q), of the protocol for the study and of the statement of the risks and anticipated benefits arising to the health of study subjects as a result of participating in the study that is set out in the informed consent form.
(4) The sponsor shall maintain all records for five years after the day on which the study ends.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.